Mindong Rejuvenation Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 359

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 2

Mindong Rejuvenation General Information

Description

Manufacturer of innovative pharmaceuticals designed for various medical areas. The specializes in the research, development, production, and sales of pharmaceutical products in various forms, including tablets, capsules and injections, with a focus on neurological treatment, digestive system treatment, anti-allergy treatment and anti-viral treatment areas, enabling patients to stay healthy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 9, Building A, Area F, Fuzhou Software Park
  • No. 89, Software Avenue, Gulou District
  • Fuzhou, Fujian
  • China
+86 0591
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Floor 9, Building A, Area F, Fuzhou Software Park
  • No. 89, Software Avenue, Gulou District
  • Fuzhou, Fujian
  • China
+86 0591

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mindong Rejuvenation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. IPO 23-Jul-2023 Cancelled Profitable
2. Later Stage VC 17-Nov-2020 Completed Profitable
1. Later Stage VC 14-Nov-2019 $4.26M $4.26M Completed Profitable
To view Mindong Rejuvenation’s complete valuation and funding history, request access »

Mindong Rejuvenation Patents

Mindong Rejuvenation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10022362-B2 Anti-allergy benzocycloheptathiophene derivatives Active 28-Jun-2011
US-20140135361-A1 Anti-allergy benzocycloheptathiophene derivatives Active 28-Jun-2011
US-20160166563-A1 Anti-allergy benzocycloheptathiophene derivatives Active 28-Jun-2011
US-9296731-B2 Anti-allergy benzocycloheptathiophene derivatives Active 28-Jun-2011 A61K31/4545

Mindong Rejuvenation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mindong Rejuvenation Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ningde State-owned Assets Investment and Operation Government Minority
Yangming Capital Venture Capital Minority
To view Mindong Rejuvenation’s complete investors history, request access »

Mindong Rejuvenation FAQs

  • When was Mindong Rejuvenation founded?

    Mindong Rejuvenation was founded in 1997.

  • Where is Mindong Rejuvenation headquartered?

    Mindong Rejuvenation is headquartered in Fuzhou, China.

  • What is the size of Mindong Rejuvenation?

    Mindong Rejuvenation has 359 total employees.

  • What industry is Mindong Rejuvenation in?

    Mindong Rejuvenation’s primary industry is Drug Discovery.

  • Is Mindong Rejuvenation a private or public company?

    Mindong Rejuvenation is a Private company.

  • What is Mindong Rejuvenation’s current revenue?

    The current revenue for Mindong Rejuvenation is .

  • How much funding has Mindong Rejuvenation raised over time?

    Mindong Rejuvenation has raised $11.8M.

  • Who are Mindong Rejuvenation’s investors?

    Ningde State-owned Assets Investment and Operation and Yangming Capital have invested in Mindong Rejuvenation.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process